Hormone replacement therapy has been used to reduce the symptoms associated with menopause
Menopause describes the permanent cessation of menstrual periods and results in the decreased production of female sex hormones (oestradiol and progesterone)
This causes symptoms such as hot flashes, vaginal dryness, night sweats and a reduction in libido
Menopausal women can be prescribed treatments of these sex hormones as a way of mitigating these symptoms
Early epidemiological studies suggested that hormone replacement therapies reduced the risk of coronary heart disease in post-menopausal women
Studies have shown that estrogen can lower cholesterol levels, promote vasodilation and reduce inflammation
More recent studies suggest that hormone replacement therapies are associated with a slightly elevated risk of coronary heart disease, breast cancer and stroke
Consequently, the use of hormone replacement therapy has decreased dramatically since the early 200s
There are multiple explanations for the disparate findings of the two studies:
The earlier study relied on observational data, while the later study involved randomised controlled trials
The observational study focused on women in their early menopausal years, while the controlled trials included women who were several years post-menopausal
Women who take hormone replacement therapy tend to be more affluent with a higher socioeconomic status, and thus have access to better healthcare
The link between hormone replacement therapy and better cardiovascular fitness may therefore have been a spurious correlation (and correlation does not equal causation)